SE423966B - Sett att framstella en steryl-glukosid-komposition med forbettrad absorptionsformaga - Google Patents

Sett att framstella en steryl-glukosid-komposition med forbettrad absorptionsformaga

Info

Publication number
SE423966B
SE423966B SE7604079A SE7604079A SE423966B SE 423966 B SE423966 B SE 423966B SE 7604079 A SE7604079 A SE 7604079A SE 7604079 A SE7604079 A SE 7604079A SE 423966 B SE423966 B SE 423966B
Authority
SE
Sweden
Prior art keywords
steryl
make
improved absorption
absorption form
glucoside composition
Prior art date
Application number
SE7604079A
Other languages
English (en)
Other versions
SE7604079L (sv
Inventor
S Inoue
M Kawamata
H Ushimaru
K Nakamichi
Y Takahashi
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of SE7604079L publication Critical patent/SE7604079L/sv
Publication of SE423966B publication Critical patent/SE423966B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
SE7604079A 1975-04-08 1976-04-07 Sett att framstella en steryl-glukosid-komposition med forbettrad absorptionsformaga SE423966B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50043008A JPS51118817A (en) 1975-04-08 1975-04-08 A process for preparing absorbable steroid glycoside pharmaceutical

Publications (2)

Publication Number Publication Date
SE7604079L SE7604079L (sv) 1976-10-09
SE423966B true SE423966B (sv) 1982-06-21

Family

ID=12651949

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7604079A SE423966B (sv) 1975-04-08 1976-04-07 Sett att framstella en steryl-glukosid-komposition med forbettrad absorptionsformaga

Country Status (11)

Country Link
US (1) US4083969A (sv)
JP (1) JPS51118817A (sv)
AT (1) AT345976B (sv)
BE (1) BE840540A (sv)
DE (1) DE2615336C3 (sv)
DK (1) DK153476A (sv)
FR (1) FR2306702A1 (sv)
GB (1) GB1503402A (sv)
MX (1) MX4258E (sv)
NL (1) NL170494C (sv)
SE (1) SE423966B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2659466A1 (de) * 1976-12-30 1979-02-15 Roecar Holdings Nv Steroline und deren verwendung
DE2759171A1 (de) * 1977-12-31 1979-07-12 Roecar Holdings Nv Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
US4254111A (en) * 1978-07-05 1981-03-03 Roecar Holdings (Netherlands Antilles) Nv Sterolin products
US4260603A (en) * 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
US4283394A (en) * 1979-08-06 1981-08-11 Research Corporation Cytotoxic nucleoside-corticosteroid phosphodiesters
JPS56113799A (en) * 1980-02-08 1981-09-07 Nippon Shinyaku Co Ltd Glucoside derivative
IE52500B1 (en) * 1981-01-23 1987-11-25 Wellcome Found Chemical complex
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
FR2616068A1 (fr) * 1987-06-04 1988-12-09 Phytland Sa Laboratoires Procede de stabilisation des principes actifs de produits vegetaux et les compositions pharmaceutiques renfermant lesdits principes actifs stabilises
US10125331B2 (en) * 2010-04-29 2018-11-13 Advanced Energy Development Renewable oil refining processes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE35018B1 (en) * 1970-03-18 1975-10-15 Liebenberg R W Therapeutic agent
DE2319873C2 (de) * 1973-04-19 1982-06-16 Boehringer Mannheim Gmbh, 6800 Mannheim 16-O-Alkylderivate von Gitoxigenin-digitoxosiden, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
US3966918A (en) * 1973-12-12 1976-06-29 Nippon Shinyaku Co., Ltd. Method of preparing aqueous solutions of sterol glycosides and their ester derivatives

Also Published As

Publication number Publication date
AT345976B (de) 1978-10-10
JPS51118817A (en) 1976-10-19
NL170494C (nl) 1983-10-17
DE2615336A1 (de) 1976-10-21
FR2306702A1 (fr) 1976-11-05
ATA243376A (de) 1978-02-15
BE840540A (fr) 1976-08-02
JPS5523245B2 (sv) 1980-06-21
FR2306702B1 (sv) 1979-09-21
DK153476A (da) 1976-10-09
US4083969A (en) 1978-04-11
MX4258E (es) 1982-03-08
NL170494B (nl) 1982-06-16
DE2615336C3 (de) 1984-08-16
SE7604079L (sv) 1976-10-09
DE2615336B2 (de) 1979-09-20
GB1503402A (en) 1978-03-08
NL7603619A (nl) 1976-10-12

Similar Documents

Publication Publication Date Title
SE433222B (sv) Sett att framstella modifierad polysackarid
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE422077B (sv) Sett att framstella syntesgas
SE7613343L (sv) Sett att framstella notande material
SE7604837L (sv) Sett att inforliva gas i karamell
SE7612532L (sv) Sett att framstella grundpalar
SE7606280L (sv) Sett att framstella etrar
MX143070A (es) Mejoras a composicion dentrifica
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE425736B (sv) Sett att framstella kromanon-(4)
SE433618B (sv) Sett att framstella en detergentkomposition i celluler partikelform
SE7606484L (sv) Sett att framstella hoghallfasta cementkonglomerat
SE423966B (sv) Sett att framstella en steryl-glukosid-komposition med forbettrad absorptionsformaga
SE418155B (sv) Sett att framstella ett oljeabsorberande material
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE427655B (sv) Sett att framstella abietamidderivat
SE7607171L (sv) Sett att framstella indolokinoliziner
SE7608939L (sv) Sett att framstella pyrrolinderivat
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE418249B (sv) Sett att framstella agglomerat
SE428471B (sv) Sett att framstella imidazolderivat
SE7601564L (sv) Sett att framstella tabletter
SE7600393L (sv) Sett att framstella filar